Literature DB >> 6802854

Treatment of acute osteomyelitis in childhood.

W G Cole, R E Dalziel, S Leitl.   

Abstract

A protocol of treatment for acute haematogenous osteomyelitis has been evaluated in 75 children. Intravenous cloxacillin and benzylpenicillin were given in hospital until the child had improved after which oral antibodies and immobilisation were continued at home for a total of six weeks. Oral cloxacillin was used most frequently as Staphylococcus aureus was the major pathogen. Simple drainage of subperiosteal pus was carried out in the 17 children with clinical evidence of an abscess. Ninety-two per cent of the 55 children with acute osteomyelitis diagnosed early were cured by a single course of antibiotics without an operation and with less than one week in hospital. Only 25 per cent of the 12 children with late-diagnosed acute osteomyelitis were cured with a single course of antibiotics and an operation. A longer period in hospital, a prolonged course of antibiotics, and secondary operations were required to cure the other children. Seven (88 per cent) of the eight neonates and infants with acute osteomyelitis were cured with a single course of antibiotics and an operation with only one to two weeks spent in hospital. The remaining infant was cured with a further course of antibiotics. The overall cure rate with a single course of treatment was 83 per cent, and the remaining children were cured with further treatment. More children would be cured with a single course of antibiotics and immobilisation without the need for surgical intervention if treated was started within one or two days of the onset of the illness rather than after four to five days when the disease is more advanced with the formation of and abscess.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802854     DOI: 10.1302/0301-620X.64B2.6802854

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  17 in total

1.  Intravenous versus oral outpatient antibiotic therapy for pediatric acute osteomyelitis.

Authors:  Raymond W Liu; Hadeel Abaza; Priyesh Mehta; Jennifer Bauer; Daniel R Cooperman; Allison Gilmore
Journal:  Iowa Orthop J       Date:  2013

Review 2.  Acute hematogenous osteomyelitis in children: recognition and management.

Authors:  Andrew C Steer; Jonathan R Carapetis
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

3.  Misconceptions about childhood acute osteomyelitis.

Authors:  Raviraj Ferdinand Stephen; Michael K D Benson; Sydney Nade
Journal:  J Child Orthop       Date:  2012-09-11       Impact factor: 1.548

4.  Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.

Authors:  R Dworkin; G Modin; S Kunz; R Rich; O Zak; M Sande
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  Acute hematogenous diaphyseal osteomyelitis in childhood.

Authors:  A A Tountas; J M Kwok
Journal:  Can Med Assoc J       Date:  1985-06-01       Impact factor: 8.262

6.  Serological diagnosis of Staphylococcus aureus osteomyelitis.

Authors:  L J Wheat; A C White; C Norden
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

Review 7.  Osteomyelitis. Common causes and treatment recommendations.

Authors:  D R Dirschl; L C Almekinders
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

8.  Bone-targeting of quinolones conjugated with an acidic oligopeptide.

Authors:  Tatsuo Takahashi; Koichi Yokogawa; Naoki Sakura; Masaaki Nomura; Shinjiro Kobayashi; Ken-ichi Miyamoto
Journal:  Pharm Res       Date:  2008-07-29       Impact factor: 4.200

9.  An implantable dosage form for the treatment of bone infections.

Authors:  A K Dash; R Suryanarayanan
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

10.  Transitioning antimicrobials from intravenous to oral in pediatric acute uncomplicated osteomyelitis.

Authors:  Nathan Batchelder; Tsz-Yin So
Journal:  World J Clin Pediatr       Date:  2016-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.